Limitations include relatively short treatment periods (6 weeks per arm), potential carryover effects despite washout, modest sample size limiting power for subgroup analyses and exclusion of newer agents (e.g., tapentadol) and long-term safety outcomes, which may restrict applicability to broader clinical practice
These include Alzheimers Disease, Infertility, Depression, and Diabetes
For CY 2026, we proposed to continue to assign CPT codes 0559T and 0561T to APC 5733 (Level 3 Minor Procedures) and status indicator Q1. We received public comments on this proposal
17,19,22,26 Given incomplete and inconsistent reporting, AE findings were summarized descriptively
What needles work best for Cagrilintide
Nitrogen retention in catabolic states (e.g., sarcopenia)